Tags

Type your tag names separated by a space and hit enter

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell. 2022 02 14; 40(2):114-116.CC

Links

PMC Free PDF

Authors+Show Affiliations

Fendler A
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Shepherd STC
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Au L
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Wilkinson KA
Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa.
Wu M
High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Schmitt AM
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Tippu Z
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Farag S
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Rogiers A
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Harvey R
Worldwide Influenza Centre, The Francis Crick Institute, London, NW1 1AT, UK.
Carlyle E
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Edmonds K
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Del Rosario L
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Lingard K
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Mangwende M
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Holt L
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Ahmod H
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Korteweg J
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Foley T
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Barber T
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Emslie-Henry A
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Caulfield-Lynch N
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Byrne F
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Shum B
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Gerard CL
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Deng D
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Kjaer S
Structural Biology STP, The Francis Crick Institute, London NW1 1AT, UK.
Song OR
High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Queval C
High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Kavanagh C
High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Wall EC
Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London, WC1E 6BT, UK.
Carr EJ
Cell Biology of Infection Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Namjou S
Safety, Health & Sustainability, The Francis Crick Institute, London, NW1 1AT, UK.
Caidan S
Safety, Health & Sustainability, The Francis Crick Institute, London, NW1 1AT, UK.
Gavrielides M
Scientific Computing Scientific Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK.
MacRae JI
Metabolomics Scientific Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK.
Kelly G
Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
Peat K
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Kelly D
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Murra A
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Kelly K
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
O'Flaherty M
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Shea RL
Department of Pathology, The Royal Marsden NHS Foundation Trust, London, NW1 1AT, UK; Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London, SW7 3RP, UK.
Gardner G
Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London, SW7 3RP, UK.
Murray D
Translational Cancer Biochemistry Laboratory, The Institute of Cancer Research, London, SW7 3RP, UK.
Yousaf N
Lung Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK; Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Jhanji S
Anaesthetics, Perioperative Medicine, and Pain Department, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Van As N
Clincal Oncology Unit, The Royal Marsden NHS Foundation Trust, London, NW1 1AT, UK.
Young K
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Furness AJS
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Pickering L
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Beale R
University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London, WC1E 6BT, UK; Division of Medicine, University College London, London NW1 2PG, UK.
Swanton C
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; University College London Cancer Institute, London WC1E 6DD, UK.
Crick COVID19 consortium
No affiliation info available
Gandhi S
Neurodegeneration Biology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Gamblin S
Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Bauer DLV
RNA Virus Replication Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Kassiotis G
Retroviral Immunology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Howell M
High Throughput Screening Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.
Nicholson E
Haemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Walker S
Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Wilkinson RJ
Tuberculosis Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Wellcome Center for Infectious Disease Research in Africa, University of Cape Town, Observatory 7925, Republic of South Africa; Department of Infectious Disease, Imperial College London, London, W12 0NN, UK.
Larkin J
Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
Turajlic S
Cancer Dynamics Laboratory, The Francis Crick Institute, London, NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. Electronic address: samra.turajlic@crick.ac.uk.
CAPTURE consortium
No affiliation info available

MeSH

Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesHematologic NeoplasmsHumansImmunization, SecondaryImmunogenicity, VaccineNeoplasmsSARS-CoV-2Symptom Assessment

Pub Type(s)

Comparative Study
Letter

Language

eng

PubMed ID

34968417

Citation

Fendler, Annika, et al. "Immune Responses Following Third COVID-19 Vaccination Are Reduced in Patients With Hematological Malignancies Compared to Patients With Solid Cancer." Cancer Cell, vol. 40, no. 2, 2022, pp. 114-116.
Fendler A, Shepherd STC, Au L, et al. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer. Cancer Cell. 2022;40(2):114-116.
Fendler, A., Shepherd, S. T. C., Au, L., Wilkinson, K. A., Wu, M., Schmitt, A. M., Tippu, Z., Farag, S., Rogiers, A., Harvey, R., Carlyle, E., Edmonds, K., Del Rosario, L., Lingard, K., Mangwende, M., Holt, L., Ahmod, H., Korteweg, J., Foley, T., ... Turajlic, S. (2022). Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer. Cancer Cell, 40(2), 114-116. https://doi.org/10.1016/j.ccell.2021.12.013
Fendler A, et al. Immune Responses Following Third COVID-19 Vaccination Are Reduced in Patients With Hematological Malignancies Compared to Patients With Solid Cancer. Cancer Cell. 2022 02 14;40(2):114-116. PubMed PMID: 34968417.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer. AU - Fendler,Annika, AU - Shepherd,Scott T C, AU - Au,Lewis, AU - Wilkinson,Katalin A, AU - Wu,Mary, AU - Schmitt,Andreas M, AU - Tippu,Zayd, AU - Farag,Sheima, AU - Rogiers,Aljosja, AU - Harvey,Ruth, AU - Carlyle,Eleanor, AU - Edmonds,Kim, AU - Del Rosario,Lyra, AU - Lingard,Karla, AU - Mangwende,Mary, AU - Holt,Lucy, AU - Ahmod,Hamid, AU - Korteweg,Justine, AU - Foley,Tara, AU - Barber,Taja, AU - Emslie-Henry,Andrea, AU - Caulfield-Lynch,Niamh, AU - Byrne,Fiona, AU - Shum,Benjamin, AU - Gerard,Camille L, AU - Deng,Daqi, AU - Kjaer,Svend, AU - Song,Ok-Ryul, AU - Queval,Christophe, AU - Kavanagh,Caitlin, AU - Wall,Emma C, AU - Carr,Edward J, AU - Namjou,Sina, AU - Caidan,Simon, AU - Gavrielides,Mike, AU - MacRae,James I, AU - Kelly,Gavin, AU - Peat,Kema, AU - Kelly,Denise, AU - Murra,Aida, AU - Kelly,Kayleigh, AU - O'Flaherty,Molly, AU - Shea,Robyn L, AU - Gardner,Gail, AU - Murray,Darren, AU - Yousaf,Nadia, AU - Jhanji,Shaman, AU - Van As,Nicholas, AU - Young,Kate, AU - Furness,Andrew J S, AU - Pickering,Lisa, AU - Beale,Rupert, AU - Swanton,Charles, AU - ,, AU - Gandhi,Sonia, AU - Gamblin,Steve, AU - Bauer,David L V, AU - Kassiotis,George, AU - Howell,Michael, AU - Nicholson,Emma, AU - Walker,Susanna, AU - Wilkinson,Robert J, AU - Larkin,James, AU - Turajlic,Samra, AU - ,, Y1 - 2021/12/29/ PY - 2021/12/31/pubmed PY - 2022/2/26/medline PY - 2021/12/30/entrez SP - 114 EP - 116 JF - Cancer cell JO - Cancer Cell VL - 40 IS - 2 SN - 1878-3686 UR - https://www.unboundmedicine.com/medline/citation/34968417/Immune_responses_following_third_COVID_19_vaccination_are_reduced_in_patients_with_hematological_malignancies_compared_to_patients_with_solid_cancer_ DB - PRIME DP - Unbound Medicine ER -